Valneva SE (VALN) Other Accumulated Expenses (2023 - 2026)
Valneva SE (VALN) posted quarterly Other Accumulated Expenses of $6.2 million for Q1 2026, up 19.69% year-on-year from $5.1 million in Q1 2025, and down 4.89% on a QoQ basis from $6.5 million in Q4 2025.
Valneva SE (VALN) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Other Accumulated Expenses for 4 consecutive years, with $6.2 million the latest figure, recorded in Q1 2026.
- Quarterly Other Accumulated Expenses rose 19.69% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (up 19.69% YoY) and the FY2025 annual result came in at $6.5 million, up 10.42% from the prior year.
- Other Accumulated Expenses slipped to $6.2 million in Q1 2026 per VALN's latest filing, from $6.5 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for VALN reached as high as $10.8 million in Q2 2025 and fell as low as $673668.9 in Q4 2023.
- A 4-year average of $6.2 million and a median of $6.2 million in 2026 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses soared 770.27% — and 2025, when it advanced 10.42%.
- Year by year, Other Accumulated Expenses stood at $673668.9 in 2023, then jumped by 770.27% to $5.9 million in 2024, then advanced by 10.42% to $6.5 million in 2025, then retreated by 4.89% to $6.2 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $6.2 million, $6.5 million, and $8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Valneva SE | 850.99 Mn | 731.20 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.16 Mn |
| Dec 31, 2025 | 6.47 Mn |
| Sep 30, 2025 | 8.57 Mn |
| Jun 30, 2025 | 10.84 Mn |
| Mar 31, 2025 | 5.14 Mn |
| Dec 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 673,668.93 |